Willow vs FitRx

Shoppers who want an oral-tablet GLP-1 at the same price as the injectable, with no annual commitment.

Reasons to consider it

• +Oral tablet formulations of both semaglutide and tirzepatide, priced the same as the injections, $299 and $399 a month
• +Month-to-month billing with no prepay or annual term required to get the advertised rate
• +Named physician team publicly listed, including Chief Medical Officer Dr. Michael Green, MD, plus 11+ other credentialed MDs/DOs

What to weigh up

• −Only 35 states and Puerto Rico are served, so residents of the other 15 states and DC can't sign up
• −Site states medication cost 'varies by dosage and prescription' but never discloses what a higher maintenance dose actually costs beyond the $299/$399 starting figures
• −Compounding pharmacy name and state are not disclosed anywhere on the site

Insured patients trying to get brand-name GLP-1s for less than list price.

Reasons to consider it

• +All 50 states + DC coverage
• +LegitScript certified
• +All four major brand-name GLP-1s (Ozempic, Wegovy, Zepbound, Mounjaro) available if insurance coordination succeeds

What to weigh up

• −The headline '$25/month' price is not a self-pay rate — it's an insurance copay the site itself hedges with 'roughly', and it depends on your plan approving a brand-name drug
• −The most prominent self-pay prices ($151 semaglutide, $216 tirzepatide) are medication only on a 3-month supply; the membership comes on top, and only its discounted $39 first month is printed
• −No named medical director, prescriber, or compounding pharmacy anywhere on the site

Regulatory note: the FDA issued a warning letter to FitRX, LLC dba FitRx in February 2026. We still list and link to FitRx; you should know the letter is on the public record before you decide.